Part 2. Scheduling of Dangerous Drugs
- 50-32-201. General criteria to be considered.
- 50-32-202. Designation of drug as dangerous drug.
- 50-32-203. Effect of rescheduling under federal law.
- 50-32-204. Immediate precursors.
- 50-32-205. Nonprescription drugs not to be scheduled.
- 50-32-206. Use of names of scheduled drugs.
- 50-32-207. Order forms for drugs in Schedules I and II.
- 50-32-208. Prescription and medical requirements for scheduled drugs -- penalty.
- 50-32-209. Republication of schedules.
- 50-32-210. through reserved.
- 50-32-221. Criteria for placement of drug in Schedule I.
- 50-32-222. Specific dangerous drugs included in Schedule I.
- 50-32-223. Criteria for placement of drug in Schedule II.
- 50-32-224. Specific dangerous drugs included in Schedule II.
- 50-32-225. Criteria for placement of drug in Schedule III.
- 50-32-226. Specific dangerous drugs included in Schedule III.
- 50-32-227. Board authorized to exempt certain compounds, mixtures, or preparations from Schedule III.
- 50-32-228. Criteria for placement of drug in Schedule IV.
- 50-32-229. Specific dangerous drugs included in Schedule IV.
- 50-32-230. Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV.
- 50-32-231. Criteria for placement of drug in Schedule V.
- 50-32-232. Specific dangerous drugs included in Schedule V.
- 50-32-233. Exempt anabolic steroid products.